(Q46614987)

23 December 2017

title

Analysis of the DPYD gene implicated in 5-fluorouracil catabolism in Chinese cancer patients (English)

1 reference

23 December 2017

1 reference

Y-F He

1

1 reference

23 December 2017

W Wei

2

1 reference

23 December 2017

X Zhang

3

1 reference

23 December 2017

Y-H Li

4

1 reference

23 December 2017

S Li

5

1 reference

23 December 2017

F-H Wang

6

1 reference

23 December 2017

X-B Lin

7

1 reference

23 December 2017

Z-M Li

8

1 reference

23 December 2017

D-S Zhang

9

1 reference

23 December 2017

H-Q Huang

10

1 reference

23 December 2017

B Hu

11

1 reference

23 December 2017

W-Q Jiang

12

1 reference

23 December 2017

publication date

1 June 2008

1 reference

23 December 2017

Journal of Clinical Pharmacy and Therapeutics

published in

1 reference

23 December 2017

volume

33

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

page(s)

307-314

1 reference

23 December 2017

Advances in pharmacogenetics and pharmacogenomics

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Genetic and environmental factors causing variation in drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Pharmacogenetic perspectives gained from twin and family studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Pharmacogenomics: unlocking the human genome for better drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Pharmacogenetics: a tool for individualizing antineoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Heterozygosity for a point mutation in an invariant splice donor site of dihydropyrimidine dehydrogenase and severe 5-fluorouracil related toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Dihydropyrimidine dehydrogenase pharmacogenetics in the Taiwanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Simple liquid chromatographic method for the determination of uracil and dihydrouracil plasma levels: a potential pretreatment predictor of 5-fluorouracil toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Germline mutation of dihydropyrimidine dehydrogenese gene among a Japanese population in relation to toxicity to 5-Fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Prediction of the response of colorectal cancer to systemic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Aberrant methylation of DPYD promoter, DPYD expression, and cellular sensitivity to 5-fluorouracil in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Effect of 5-fluorouracil and epidermal growth factor on cell growth and dihydropyrimidine dehydrogenase regulation in human uterine cervical carcinoma SKG-IIIb cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2008.00898.X

10.1111/J.1365-2710.2008.00898.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017